Alovudine (BioDeep_00000730798)

   


代谢物信息卡片


Alovudine

化学式: C10H13FN2O4 (244.0859)
中文名称: 阿洛夫定
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
InChI: InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1

描述信息

C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor
D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
C254 - Anti-Infective Agent > C281 - Antiviral Agent
Alovudine (3'-Fluoro-3'-deoxythymidine) is a marker of DNA synthesis that is less susceptible to inflammatory changes than 18F-Fluorodeoxyglucose (FDG) and thus is a better biomarker in pancreatic cancer. Alovudine shows anti-orthopoxvirus activity[1][2].

同义名列表

4 个代谢物同义名

Alovudine; 3'-Fluoro-3'-deoxythymidine; 3′-Deoxy-3′-fluorothymidine; FLT



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Kathrin Heinzmann, Quang-Dé Nguyen, Davina Honess, Donna-Michelle Smith, Stephen Stribbling, Diana Brickute, Chris Barnes, John Griffiths, Eric Aboagye. Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using 18F-ICMT-11 and 18F-FLT PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2018 10; 59(10):1558-1565. doi: 10.2967/jnumed.118.209304. [PMID: 29794225]
  • Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L Powers, Yongjun Yan, Kooresh I Shoghi, Aparna M Mahajan, Amy M Fowler. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2018 05; 59(5):833-838. doi: 10.2967/jnumed.117.199406. [PMID: 29217733]
  • Gerbrand Maria Kramer, Virginie Frings, Dennis Heijtel, E F Smit, Otto S Hoekstra, Ronald Boellaard. Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2017 06; 58(6):920-925. doi: 10.2967/jnumed.116.178418. [PMID: 28572289]
  • Hang Jung Lee, DO Hyung Kim, Seung Jin Lee. 17-Allylamino-17-demethoxygeldanamycin-induced Changes in [18F]Fluorothymidine Uptake. Anticancer research. 2017 06; 37(6):2993-2999. doi: 10.21873/anticanres.11653. [PMID: 28551637]
  • Xiao Jiang, Xiao-Xiong Wang, Hao Lu, Shi-Rong Chen, Ding-Qiong Xiao, Meng Zhao, Xiu-Li Li, Ge Zhang, Guo-Hui Xu, Zhu-Zhong Cheng. [Quality Control and Biological Assessment of Automated Synthesized 3'-deoxy-3'-¹⁸F-fluorothymidine using CFN-MPS-200 Module]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. 2017 Mar; 48(2):295-298. doi: NULL. [PMID: 28612546]
  • Matthew Scarpelli, Justine Yang Bruce, Lakeesha Carmichael, Jens Eickhoff, Jill Kolesar, Scott Perlman, Robert Jeraj, Glenn Liu. 18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen. Cancer chemotherapy and pharmacology. 2016 Dec; 78(6):1245-1252. doi: 10.1007/s00280-016-3183-7. [PMID: 27817059]
  • Debanti Sengupta, Guillem Pratx. Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 07; 57(7):1136-40. doi: 10.2967/jnumed.115.167734. [PMID: 27081170]
  • Lale Kostakoglu, Fenghai Duan, Michael O Idowu, Paul R Jolles, Harry D Bear, Mark Muzi, Jean Cormack, John P Muzi, Daniel A Pryma, Jennifer M Specht, Linda Hovanessian-Larsen, John Miliziano, Sharon Mallett, Anthony F Shields, David A Mankoff. A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2015 Nov; 56(11):1681-9. doi: 10.2967/jnumed.115.160663. [PMID: 26359256]
  • Kevin P Horn, Jeffrey T Yap, Neeraj Agarwal, Kathryn A Morton, Dan J Kadrmas, Britney Beardmore, Regan I Butterfield, Kenneth Boucher, John M Hoffman. FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma. Cancer imaging : the official publication of the International Cancer Imaging Society. 2015 Sep; 15(?):15. doi: 10.1186/s40644-015-0049-x. [PMID: 26335224]
  • Justine Yang Bruce, Peter Colin Scully, Lakeesha L Carmichael, Jens C Eickhoff, Scott B Perlman, Jill Marie Kolesar, Jennifer L Heideman, Robert Jeraj, Glenn Liu. Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography. Cancer chemotherapy and pharmacology. 2015 Jul; 76(1):187-95. doi: 10.1007/s00280-015-2779-7. [PMID: 26021741]
  • C Lauri, S Di Traglia, F Galli, P Pizzichini, A Signore. Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 2015 Mar; 59(1):105-15. doi: NULL. [PMID: 25737424]
  • M Peck, H A Pollack, A Friesen, M Muzi, S C Shoner, E G Shankland, J R Fink, J O Armstrong, J M Link, K A Krohn. Applications of PET imaging with the proliferation marker [18F]-FLT. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 2015 Mar; 59(1):95-104. doi: NULL. [PMID: 25737423]
  • Bhanu P Pemmaraju, Swapnil Malekar, Hitesh K Agarwal, Rakesh K Tiwari, Donghoon Oh, Gustavo F Doncel, David R Worthen, Keykavous Parang. Design, synthesis, antiviral activity, and pre-formulation development of poly-L-arginine-fatty acyl derivatives of nucleoside reverse transcriptase inhibitors. Nucleosides, nucleotides & nucleic acids. 2015; 34(1):1-15. doi: 10.1080/15257770.2014.945649. [PMID: 25513860]
  • Sorin Armeanu-Ebinger, Christoph M Griessinger, Delia Herrmann, Jörg Fuchs, Manfred Kneilling, Bernd J Pichler, Guido Seitz. PET/MR imaging and optical imaging of metastatic rhabdomyosarcoma in mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2014 Sep; 55(9):1545-51. doi: 10.2967/jnumed.114.138578. [PMID: 24963126]
  • Virginie Frings, Maqsood Yaqub, Lieke L Hoyng, Sandeep S V Golla, Albert D Windhorst, Robert C Schuit, Adriaan A Lammertsma, Otto S Hoekstra, Egbert F Smit, Ronald Boellaard. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2014 Sep; 55(9):1417-23. doi: 10.2967/jnumed.114.140913. [PMID: 24970910]
  • M Veronese, G Rizzo, E O Aboagye, A Bertoldo. Parametric imaging of ¹⁸F-fluoro-3-deoxy-3-L-fluorothymidine PET data to investigate tumour heterogeneity. European journal of nuclear medicine and molecular imaging. 2014 Sep; 41(9):1781-92. doi: 10.1007/s00259-014-2757-z. [PMID: 24705620]
  • Virginie Frings, Adrianus J de Langen, Maqsood Yaqub, Robert C Schuit, Astrid A M van der Veldt, Otto S Hoekstra, Egbert F Smit, Ronald Boellaard. Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer. Molecular imaging and biology. 2014 Feb; 16(1):136-45. doi: 10.1007/s11307-013-0658-3. [PMID: 23813332]
  • György Trencsényi, Teréz Márián, Imre Lajtos, Zoltán Krasznai, László Balkay, Miklós Emri, Pál Mikecz, Katalin Goda, Gábor Szalóki, István Juhász, Enikő Németh, Tünde Miklovicz, Gábor Szabó, Zoárd T Krasznai. 18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts. BioMed research international. 2014; 2014(?):787365. doi: 10.1155/2014/787365. [PMID: 25309926]
  • Kerstin Fuchs, Ursula Kohlhofer, Leticia Quintanilla-Martinez, Denis Lamparter, Ina Kötter, Gerald Reischl, Martin Röcken, Bernd J Pichler, Manfred Kneilling. In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2013 Jan; 54(1):151-8. doi: 10.2967/jnumed.112.106740. [PMID: 23213198]
  • Virginie Frings, Astrid A M van der Veldt, Ronald Boellaard, Gerarda J M Herder, Elisa Giovannetti, Richard Honeywell, Godefridus J Peters, Erik Thunnissen, Otto S Hoekstra, Egbert F Smit. Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography. PloS one. 2013; 8(5):e63705. doi: 10.1371/journal.pone.0063705. [PMID: 23717468]
  • Morse Faria, Matthew S Halquist, Erick Kindt, Wenlin Li, H Thomas Karnes, Peter J O'Brien. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2012 Oct; 907(?):13-20. doi: 10.1016/j.jchromb.2012.08.024. [PMID: 22995377]
  • G Tomasi, S Kimberley, L Rosso, E Aboagye, F Turkheimer. Double-input compartmental modeling and spectral analysis for the quantification of positron emission tomography data in oncology. Physics in medicine and biology. 2012 Apr; 57(7):1889-906. doi: 10.1088/0031-9155/57/7/1889. [PMID: 22421332]
  • Cathy C Zhang, Zhengming Yan, Wenlin Li, Kyle Kuszpit, Cory L Painter, Qin Zhang, Patrick B Lappin, Tim Nichols, Maruja E Lira, Timothy Affolter, Neeta R Fahey, Carleen Cullinane, Mary Spilker, Kenneth Zasadny, Peter O'Brien, Dana Buckman, Anthony Wong, James G Christensen. [(18)F]FLT-PET imaging does not always 'light up' proliferating tumor cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Mar; 18(5):1303-12. doi: 10.1158/1078-0432.ccr-11-1433. [PMID: 22170262]
  • Glenn Liu, Robert Jeraj, Matt Vanderhoek, Scott Perlman, Jill Kolesar, Michael Harrison, Urban Simoncic, Jens Eickhoff, Lakeesha Carmichael, Bo Chao, Rebecca Marnocha, Percy Ivy, George Wilding. Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Dec; 17(24):7634-44. doi: 10.1158/1078-0432.ccr-11-1677. [PMID: 22038997]
  • Robert J Paproski, Melinda Wuest, Hans-Sonke Jans, Kathryn Graham, Wendy P Gati, Steve McQuarrie, Alexander McEwan, John Mercer, James D Young, Carol E Cass. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010 Sep; 51(9):1447-55. doi: 10.2967/jnumed.110.076356. [PMID: 20720035]
  • Malik E Juweid, Damita Thomas, Yusuf Menda, Timothy Tewson, Michael M Graham, Ken Herrmann, Andreas K Buck, Luis Fayad. PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010 May; 51(5):824-5. doi: 10.2967/jnumed.110.075945. [PMID: 20439512]
  • David M Vail, Douglas H Thamm, Hans Reiser, Adrian S Ray, Grushenka H I Wolfgang, William J Watkins, Darius Babusis, Ilana N Henne, Michael J Hawkins, Ilene D Kurzman, Robert Jeraj, Matt Vanderhoek, Susan Plaza, Christie Anderson, Mackenzie A Wessel, Cecilia Robat, Jessica Lawrence, Daniel B Tumas. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 May; 15(10):3503-10. doi: 10.1158/1078-0432.ccr-08-3113. [PMID: 19417014]
  • Adrianus J de Langen, Bianca Klabbers, Mark Lubberink, Ronald Boellaard, Marieke D Spreeuwenberg, Ben J Slotman, Remco de Bree, Egbert F Smit, Otto S Hoekstra, Adriaan A Lammertsma. Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography. European journal of nuclear medicine and molecular imaging. 2009 Mar; 36(3):389-95. doi: 10.1007/s00259-008-0960-5. [PMID: 18931838]
  • S J Price, T D Fryer, M C Cleij, A F Dean, J Joseph, R Salvador, D D Wang, P J Hutchinson, J C Clark, N G Burnet, J D Pickard, F I Aigbirhio, J H Gillard. Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study. Clinical radiology. 2009 Jan; 64(1):52-63. doi: 10.1016/j.crad.2008.01.016. [PMID: 19070698]
  • Su Jin Kim, Jae Sung Lee, Ki Chum Im, Seog-Young Kim, Soo-Ah Park, Seung Jin Lee, Seung Jun Oh, Dong Soo Lee, Dae Hyuk Moon. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008 Dec; 49(12):2057-66. doi: 10.2967/jnumed.108.053215. [PMID: 18997037]
  • Robert J Paproski, Amy M L Ng, Sylvia Y M Yao, Kathryn Graham, James D Young, Carol E Cass. The role of human nucleoside transporters in uptake of 3'-deoxy-3'-fluorothymidine. Molecular pharmacology. 2008 Nov; 74(5):1372-80. doi: 10.1124/mol.108.048900. [PMID: 18669604]
  • Nobuhiro Kanaji, Shuji Bandoh, Koshiro Takano, Kyuichi Kadota, Reiji Haba, Toru Matsunaga, Kohoji Kohno, Yoshio Kushida, Yuka Yamamoto, Toshihiko Ishida. Positron emission tomography-positive squalene-induced lipoid pneumonia confirmed by gas chromatography-mass spectrometry of bronchoalveolar lavage fluid. The American journal of the medical sciences. 2008 Apr; 335(4):310-4. doi: 10.1097/maj.0b013e31811ec1a0. [PMID: 18414072]
  • Andreas T J Vogg, Andreas K Buck, Michaela Schmid, Bernd Neumaier, Katrin Wczasek, Boris D Zlatopolskiy, Sven N Reske. Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT. Nuclear medicine and biology. 2007 Apr; 34(3):273-81. doi: 10.1016/j.nucmedbio.2006.12.010. [PMID: 17383577]
  • Andrew R Hsu, Weibo Cai, Anand Veeravagu, Khalid A Mohamedali, Kai Chen, Sehoon Kim, Hannes Vogel, Lewis C Hou, Victor Tse, Michael G Rosenblum, Xiaoyuan Chen. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2007 Mar; 48(3):445-54. doi: ". [PMID: 17332623]
  • Nathan Lawrentschuk, A M T Poon, A M Scott. Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumors. Clinical nuclear medicine. 2006 Dec; 31(12):788-9. doi: 10.1097/01.rlu.0000247310.05362.83. [PMID: 17117073]
  • Laura M Kenny, David M Vigushin, Adil Al-Nahhas, Safiye Osman, Sajinder K Luthra, Sami Shousha, R Charles Coombes, Eric O Aboagye. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer research. 2005 Nov; 65(21):10104-12. doi: 10.1158/0008-5472.can-04-4297. [PMID: 16267037]
  • Jeffrey R Tseng, Mangal Dandekar, Murugesan Subbarayan, Zhen Cheng, Jinha M Park, Stan Louie, Sanjiv S Gambhir. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Nov; 46(11):1851-7. doi: NULL. [PMID: 16269599]
  • Mark Muzi, David A Mankoff, John R Grierson, Joanne M Wells, Hubert Vesselle, Kenneth A Krohn. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Feb; 46(2):371-80. doi: NULL. [PMID: 15695799]
  • Mark Muzi, Hubert Vesselle, John R Grierson, David A Mankoff, Rodney A Schmidt, Lanell Peterson, Joanne M Wells, Kenneth A Krohn. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Feb; 46(2):274-82. doi: NULL. [PMID: 15695787]
  • Christine Katlama, Jade Ghosn, Roland Tubiana, Marc Wirden, Marc-Antoine Valantin, Johan Harmenberg, Göran Mårdh, Bo Oberg, Vincent Calvez. MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study. AIDS (London, England). 2004 Jun; 18(9):1299-304. doi: 10.1097/00002030-200406180-00008. [PMID: 15362662]
  • Aren van Waarde, David C P Cobben, Albert J H Suurmeijer, Bram Maas, Willem Vaalburg, Erik F J de Vries, Pieter L Jager, Harald J Hoekstra, Philip H Elsinga. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Apr; 45(4):695-700. doi: NULL. [PMID: 15073267]
  • D Visvikis, D Francis, R Mulligan, D C Costa, I Croasdale, S K Luthra, I Taylor, P J Ell. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer. European journal of nuclear medicine and molecular imaging. 2004 Feb; 31(2):169-78. doi: 10.1007/s00259-003-1339-2. [PMID: 15129698]
  • Karin Lindén, Lars Ståhle, Ewa Ljungdahl-Ståhle, Natalia Borg. Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis. Pharmacology & toxicology. 2003 Nov; 93(5):226-32. doi: 10.1046/j.1600-0773.2003.pto930505.x. [PMID: 14629734]
  • Henryk Barthel, Marcel C Cleij, David R Collingridge, O Clyde Hutchinson, Safiye Osman, Qimin He, Sajinder K Luthra, Frank Brady, Pat M Price, Eric O Aboagye. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer research. 2003 Jul; 63(13):3791-8. doi: NULL. [PMID: 12839975]
  • Li Lu, Linda Samuelsson, Mats Bergström, Kengo Sato, Karl-Johan Fasth, Bengt Långström. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002 Dec; 43(12):1688-98. doi: NULL. [PMID: 12468521]
  • K Parang, E E Knaus, L I Wiebe. Synthesis, in vitro anti-HIV activity, and biological stability of 5'-O-myristoyl analogue derivatives of 3'-fluoro-2',3'-dideoxythymidine (FLT) as potential bifunctional prodrugs of FLT. Nucleosides & nucleotides. 1998 Jun; 17(6):987-1008. doi: 10.1080/07328319808004216. [PMID: 9708320]
  • C Flexner, C van der Horst, M A Jacobson, W Powderly, F Duncanson, D Ganes, P A Barditch-Crovo, B G Petty, P A Baron, D Armstrong. Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. The Journal of infectious diseases. 1994 Dec; 170(6):1394-403. doi: 10.1093/infdis/170.6.1394. [PMID: 7995977]
  • S M Daluge, D J Purifoy, P M Savina, M H St Clair, N R Parry, I K Dev, P Novak, K M Ayers, J E Reardon, G B Roberts. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Antimicrobial agents and chemotherapy. 1994 Jul; 38(7):1590-603. doi: 10.1128/aac.38.7.1590. [PMID: 7526782]
  • L Ståhle, E Guzenda, E Ljungdahl-Ståhle. Pharmacokinetics and extracellular distribution to blood, brain, and muscle of alovudine (3'-fluorothymidine) and zidovudine in the rat studied by microdialysis. Journal of acquired immune deficiency syndromes. 1993 May; 6(5):435-9. doi: NULL. [PMID: 8483107]
  • B E Korba, J L Gerin. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral research. 1992 Jul; 19(1):55-70. doi: 10.1016/0166-3542(92)90056-b. [PMID: 1444322]
  • X B Kong, Q Y Zhu, P M Vidal, K A Watanabe, B Polsky, D Armstrong, M Ostrander, S A Lang, E Muchmore, T C Chou. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Antimicrobial agents and chemotherapy. 1992 Apr; 36(4):808-18. doi: 10.1128/aac.36.4.808. [PMID: 1503443]
  • F D Boudinot, S G Smith, E D Funderburg, R F Schinazi. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rats. Antimicrobial agents and chemotherapy. 1991 Apr; 35(4):747-9. doi: 10.1128/aac.35.4.747. [PMID: 1648888]
  • B Lundgren, D Böttiger, E Ljungdahl-Ståhle, E Norrby, L Ståhle, B Wahren, B Oberg. Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. Journal of acquired immune deficiency syndromes. 1991; 4(5):489-98. doi: . [PMID: 2016686]
  • R F Schinazi, F D Boudinot, K J Doshi, H M McClure. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys. Antimicrobial agents and chemotherapy. 1990 Jun; 34(6):1214-9. doi: 10.1128/aac.34.6.1214. [PMID: 2168144]